francesca’s® Announces Reporting Date for Fourth Quarter and Fiscal Year 2017 Financial Results
Mar 13, 2018 20:05 pm UTC| Business
HOUSTON, March 13, 2018 -- Francesca’s Holdings Corporation (Nasdaq:FRAN) today announced plans to report fourth quarter and fiscal year 2017 financial results on Tuesday, March 27, 2018, before the market opens. The...
Mar 13, 2018 20:05 pm UTC| Business
YAVNE, Israel, March 13, 2018 -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that...
Arbor Realty Trust, Inc. Closes Offering of Senior Notes due 2023
Mar 13, 2018 20:05 pm UTC| Business
UNIONDALE, N.Y., March 13, 2018 -- Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) closed today its private placement to eligible purchasers of $100 million in aggregate principal amount of 5.625% senior unsecured...
Heartland Express, Inc. Declares Regular Quarterly Dividend
Mar 13, 2018 20:02 pm UTC| Business
NORTH LIBERTY, Iowa, March 13, 2018 -- The Board of Directors of Heartland Express, Inc. (Nasdaq:HTLD) announced today the declaration of a regular quarterly cash dividend. The $0.02 per share dividend will be paid on...
The Children’s Place to Webcast Review of Fourth Quarter and Fiscal Year 2017 Financial Results
Mar 13, 2018 20:02 pm UTC| Business
SECAUCUS, N.J., March 13, 2018 -- The Children’s Place, Inc. (Nasdaq:PLCE) today announced that in conjunction with the release of its Fourth Quarter and Fiscal Year 2017 financial results, you are invited to listen to...
Trevali Reports 2017 Annual Financial Results
Mar 13, 2018 20:01 pm UTC| Business
EBITDA(1) of $101 million on net revenues of $330.5 million;Cash position of $97.3 million and working capital of $144 million;Net profit of $20.2-million or $0.03 per share;Adjusted EBITDA(1) (5) (6) of $162 million and...
Supernus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes
Mar 13, 2018 20:01 pm UTC| Business
ROCKVILLE, Md., March 13, 2018 -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) (the “Company”), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous...